Quick Answer
Zhengye Biotechnology Holding Ltd reported Cash and Equivalents of $2.55 million for fiscal year 2024.
Zhengye Biotechnology Holding Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $2.55M | -83.1% |
| 2023 | $15.07M | — |
- Zhengye Biotechnology Holding Ltd showed a decrease of -83.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2024 period, Zhengye Biotechnology Holding Ltd’s cash and equivalents has declined by 83.1% (from $15.07 million to $2.55 million).
- The most recent figure is from Zhengye Biotechnology Holding Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on July 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: